Curis | CRIS - Ordinary Share Capital


Curis reported $12.93M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.21M 131K Sep/2025
Amgen USD 540M 1000K Mar/2026
AstraZeneca USD 1.55B 73K Mar/2026
Bayer EUR 982.42M 0 Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
CSL USD 482.13M 93.87M Dec/2025
Curis USD 12.93M 12.87M Dec/2025
Eli Lilly USD 943.5M 3.33M Mar/2026
Exelixis USD 253.7M 8.78M Mar/2026
Gilead Sciences USD 1.24B 1000K Mar/2026
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
Incyte USD 199.95M 1.49M Mar/2026
Merck USD 2.47B 12.72M Dec/2025
Novartis USD 1.91B 60K Mar/2026
Pfizer USD 5.7B 13M Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
Takeda JPY 1.58B 241K Mar/2026
TG Therapeutics USD 155.31M 95K Dec/2025
Verastem USD 77.74M 77.74M Dec/2025
Xoma USD 87K 1000 Jun/2024